APA (7th ed.) Citation

M, T., M, L., A, B., I, C., J, M., P, K., . . . K, A. (2026). Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial). Hepatology (Baltimore, Md.). https://doi.org/10.1097/HEP.0000000000001821

Chicago Style (17th ed.) Citation

M, Thursz, et al. "Nucleos(t)ide Withdrawal Vs Nucleos(t)ide Withdrawal with Adjuvant Pegylated-interferon in HBeAg-negative Hepatitis B Virus Infection (NUC-B Trial)." Hepatology (Baltimore, Md.) 2026. https://doi.org/10.1097/HEP.0000000000001821.

MLA (9th ed.) Citation

M, Thursz, et al. "Nucleos(t)ide Withdrawal Vs Nucleos(t)ide Withdrawal with Adjuvant Pegylated-interferon in HBeAg-negative Hepatitis B Virus Infection (NUC-B Trial)." Hepatology (Baltimore, Md.), 2026, https://doi.org/10.1097/HEP.0000000000001821.